Seattle, WA, United States of America

Eileen R Mulvihill



Average Co-Inventor Count = 3.9

ph-index = 6

Forward Citations = 125(Granted Patents)


Location History:

  • Seattle, WA (US) (1992 - 1999)
  • Mercer Island, WA (US) (1998 - 2001)

Company Filing History:


Years Active: 1992-2001

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Eileen R. Mulvihill: Innovator in Glutamate Receptor Research

Introduction

Eileen R. Mulvihill is a prominent inventor based in Seattle, WA (US). She has made significant contributions to the field of neuroscience, particularly in the study of glutamate receptors. With a total of 12 patents to her name, her work has advanced our understanding of neuronal communication.

Latest Patents

Among her latest patents, Eileen has developed methods related to L-AP4 sensitive glutamate receptors. The metabotropic receptor mGluR7 has been identified and sequenced, revealing its role in mediating inhibition of transmitter release at selected glutamatergic synapses. Additionally, her work on G protein coupled glutamate receptors has led to their identification, isolation, and purification. These receptors have been cloned, sequenced, and expressed through recombinant means, paving the way for new diagnostic and therapeutic methods.

Career Highlights

Eileen has worked with notable organizations such as Zymogenetics, Inc. and the University of Washington. Her research has not only contributed to academic knowledge but has also had practical applications in the medical field.

Collaborations

Eileen has collaborated with esteemed colleagues, including Frederick S. Hagen and Khaled M. Houamed. These partnerships have further enriched her research and expanded the impact of her inventions.

Conclusion

Eileen R. Mulvihill's innovative work in glutamate receptor research exemplifies her dedication to advancing neuroscience. Her numerous patents and collaborations highlight her significant contributions to the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…